Learn more about BioOra
New Zealand, NZ · 3 known investors
BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.